Archive for the ‘MRK Stock’ Category

Daily Dividend Report: MRK, BLL, SPW, ORI, MKC

Wednesday, November 25th, 2009

Daily Dividend Report: MRK, BLL, SPW, ORI, MKC
MarketNewsVideo.com – 17 hours ago
Yesterday afternoon, Merck (NYSE:MRK) declared its quarterly dividend of thirty eight cents per share, maintaining the amount paid last quarter. With the dividend, the company also announced it …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

A Big Upgrade for Amylin Pharmaceuticals – Motley Fool

Wednesday, November 25th, 2009

The Money Times A Big Upgrade for Amylin Pharmaceuticals Motley Fool Amylin and partner Eli Lilly (NYSE: LLY) are up against competitors like Merck (NYSE: MRK ) and Bristol-Myers Squibb (NYSE: BMY) in a market to treat … Are These Dividends Too Good to Be True? Motley Fool all 78 news articles »

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

PROLOR Biotech Reports Merck Receives Positive Regulatory Opinion

Wednesday, November 25th, 2009

PROLOR Biotech Reports Merck Receives Positive Regulatory Opinion
Trading Markets – 22 hours ago
Nov 25, 2009 (Al-Bawaba via COMTEX) — PBTH — PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the positive opinion by the Committee for MedicinalProducts for Human Use (CHMP) of the …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Merck Serono Launches New Website on Phenylketonuria

Wednesday, November 25th, 2009

Merck Serono Launches New Website on Phenylketonuria

Merck Serono Launches New Website on Phenylketonuria
Trading Markets – 1 hour ago
GENEVA, Nov 25, 2009 (PR Newswire Europe via COMTEX) — MKGAY — Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the launch of a website dedicated to phenylketonuria …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

NicOx sees naproxcinod deal by 2011 launch – Forbes

Wednesday, November 25th, 2009

NicOx sees naproxcinod deal by 2011 launch – Forbes

NicOx sees naproxcinod deal by 2011 launch Forbes Merck ( MRK – news – people )'s painkiller Vioxx was withdrawn in 2004 after a clinical trial found the blockbuster drug increased the risk of heart attacks … and more »

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

Merck’s Relief in Texas – Analyst Blog – Benzinga

Wednesday, November 25th, 2009

Merck’s Relief in Texas – Analyst Blog – Benzinga

Reuters Merck's Relief in Texas – Analyst Blog Benzinga Although Merck ( MRK ) is aiming to close the Vioxx chapter, it is far from over. The company's long list of cases is still pending. … Merck Wins Vioxx Judgment in Texas ( MRK ) Dividend.com (blog) Merck (NYSE: MRK ) Claims Win in Vioxx Lawsuit in Texas TransWorldNews (press release) all 195 news articles »

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

Market Report — In Play (IDRA) – MSN Money

Wednesday, November 25th, 2009

Market Report — In Play (IDRA) – MSN Money

Market Report — In Play (IDRA) MSN Money Idera Pharma and Merck extend research collaboration for agonists of toll-like receptors as vaccine adjuvants Co announces that Merck ( MRK ) has extended its … and more »

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants

Wednesday, November 25th, 2009

Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants

Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
Business Wire – 3 hours ago
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a …
Idera Pharma (IDRA) Extends TLR Research Collaboration with Merck (MRK) – StreetInsider.com
Idera Says Merck Extends Research Collaboration To Fourth Year; Ends Asthma, Allergy Research With Novartis – Update – RTT News
Mass High Tech

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Idera Pharmaceuticals, Inc. And Merck & Co., Inc. Extend Research Collaboration For Agonists Of Toll-like Receptors As Vaccine Adjuvants

Wednesday, November 25th, 2009

Idera Pharmaceuticals, Inc. And Merck & Co., Inc. Extend Research Collaboration For Agonists Of Toll-like Receptors As Vaccine Adjuvants

Idera Pharmaceuticals, Inc. And Merck & Co., Inc. Extend Research Collaboration For Agonists Of Toll-like Receptors As Vaccine Adjuvants
Reuters Key Development – 3 hours ago

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Wall Street Breakfast: Must-Know News – Seeking Alpha (blog)

Wednesday, November 25th, 2009

Wall Street Breakfast: Must-Know News – Seeking Alpha (blog)

Wall Street Breakfast: Must-Know News Seeking Alpha (blog) Merck ( MRK ), which issued $45B in stock to buy Schering-Plough and has a market valuation around $110B, will buyback $3B of that stock as it looks to put …

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .